Skip to Content

M 106 (Zidovudine 300 mg)

Pill with imprint M 106 is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Mylan Pharmaceuticals Inc..

Zidovudine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 106

Zidovudine 300 mg M 106

Zidovudine

Imprint:
M 106
Strength:
300 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide